UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

Proceedings of the National Academy of Sciences - PNAS, 2009-02, Vol.106 (6), p.1971-1976

2009

Volltextzugriff (PDF)

Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease

Neuropharmacology, 2020-07, Vol.171, p.108115-108115, Article 108115

2020

Volltextzugriff (PDF)

Soluble oligomers from a non-disease related protein mimic Aβ-induced tau hyperphosphorylation and neurodegeneration

Journal of neurochemistry, 2007-10, Vol.103 (2), p.736-748

2007

Volltextzugriff (PDF)

Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets

Neuropharmacology, 2018-07, Vol.136 (Pt B), p.160-171

2018

Volltextzugriff (PDF)

Insulin Resistance in Alzheimer's Disease

Frontiers in neuroscience, 2018-11, Vol.12, p.830-830

2018

Volltextzugriff (PDF)

Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP)

The Journal of biological chemistry, 2004-10, Vol.279 (41), p.42803-42810

2004

Volltextzugriff (PDF)

Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

IUBMB life, 2007, Vol.59 (4‐5), p.332-345

2007

Volltextzugriff (PDF)

Training Microglia to Resist Alzheimer's Disease

The Journal of neuroscience, 2017-01, Vol.37 (3), p.477-479

2017

Volltextzugriff (PDF)

Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?

Frontiers in aging neuroscience, 2017-01, Vol.9, p.7-7

2017

Volltextzugriff (PDF)

Structural changes in the obese brain

Neural regeneration research, 2024-12, Vol.19 (12), p.2561-2562

2024

Volltextzugriff (PDF)

P4-263: Insulin prevents the pathological impact of soluble Abeta oligomers on neuronal insulin receptors

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T748-T748

2008

Volltextzugriff (PDF)

Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization

The FASEB journal, 2004-09, Vol.18 (12), p.1366-1372

2004

Volltextzugriff (PDF)

Formation of amyloid aggregates from human lysozyme and its disease‐associated variants using hydrostatic pressure

The FASEB journal, 2004-07, Vol.18 (10), p.1099-1101

2004

Volltextzugriff (PDF)

Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra

Journal of neurochemistry, 2005-03, Vol.92 (5), p.1021-1032

2005

Volltextzugriff (PDF)

Small molecule inhibitors of lysozyme amyloid aggregation

Cell biochemistry and biophysics, 2006-01, Vol.44 (3), p.549-553

2006

Volltextzugriff (PDF)

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of AÎ² oligomers

Proceedings of the National Academy of Sciences - PNAS, 2009, Vol.106 (6), p.1971-1976

2009

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease

Soluble oligomers from a non-disease related protein mimic Aβ-induced tau hyperphosphorylation and neurodegeneration

Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets

Insulin Resistance in Alzheimer's Disease

Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP)

Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

Training Microglia to Resist Alzheimer's Disease

Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?

Structural changes in the obese brain

P4-263: Insulin prevents the pathological impact of soluble Abeta oligomers on neuronal insulin receptors

Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization

Formation of amyloid aggregates from human lysozyme and its disease‐associated variants using hydrostatic pressure

Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra

Small molecule inhibitors of lysozyme amyloid aggregation

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of AÎ² oligomers

Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020

Suchergebnisse filtern